Bioness Medical Secures $15M Debt Financing from Horizon Technology Finance

Bioness Medical, a Valencia, California-based medical technology company specializing in neurorehabilitation, has raised $15 million in debt financing. The round was led by Horizon Technology Finance Corporation, according to a filing dated September 2, 2026.

Company Overview

Bioness Medical develops and commercializes FDA-approved neurorehabilitation technologies for individuals recovering from stroke, spinal cord injury, and other neurological conditions. Its product portfolio spans functional electrical stimulation, robotic gait training, and neuromodulation, supporting clinicians and healthcare systems across hospital, outpatient, and home-based care settings worldwide.

The company is backed by Accelmed Partners and led by co-founder and CEO Todd Cushman. It holds a leading position in the neurorehabilitation market with clinically validated products.

Funding Details

The debt financing of $15 million was provided by Horizon Technology Finance Corporation. This capital is expected to support Bioness Medical's ongoing operations and growth initiatives, though specific uses were not disclosed.

About Horizon Technology Finance

Horizon Technology Finance Corporation is a specialty finance company that provides capital to life science and technology companies. The firm focuses on venture debt and other secured loans to emerging growth companies.

Implications

This debt financing adds to Bioness Medical's financial resources, enabling the company to continue its mission of advancing neurorehabilitation care. With a strong product portfolio and market presence, the company is well-positioned to leverage this funding for future developments.

Note: This article is based solely on the provided funding announcement and company description. No additional details were available.